Search results
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters via Yahoo Finance· 1 day agoSHANGHAI (Reuters) -Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval...
GSK intends to sell its remaining stake in Haleon
WSAU Wausau· 6 days ago(Reuters) - British drugmaker GSK said on Thursday it plans to sell about 385 million shares, representing its entire shareholding, in spun-off consumer...
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports By Reuters
Investing.com· 6 days agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper...
Cipla receives final USFDA nod for Lanreotide injection to treat tumours
Investing.com· 8 hours agoCipla receives final USFDA nod for Lanreotide injection to treat tumours
GSK to Sell Remaining $1.6 Billion Stake in Haleon
Bloomberg· 6 days agoGSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the consumer health...
People using popular drugs for weight loss, diabetes are more likely to be diagnosed with stomach...
KITV Honolulu· 2 days agoAt least three new studies based on large collections of patient records show that the risk of being...
AstraZeneca aims for $80 billion in total revenue by 2030
Colorado Springs Gazette· 1 day agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines between 2023 and 2030. CEO Pascal ...
AstraZeneca aims for $80 billion in total revenue by 2030
AOL· 1 day agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines between 2023 and 2030. CEO Pascal ...
GSK Experimental Drug Reduces Severe Asthma Attacks in Key Trial
Bloomberg· 1 day agoAn experimental drug from GSK Plc reduced asthma attacks in late-stage trials, paving the way for a...
GSK raises $1.5 billion from sale of remaining Haleon stake
Reuters via Yahoo Finance· 5 days agoThe sale will allow GSK to sharpen its focus on vaccines, cancer and infectious diseases, which are...